Predictive Technology Profit Margin 2017-2021 | PRED

Current and historical gross margin, operating margin and net profit margin for Predictive Technology (PRED) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Predictive Technology net profit margin as of March 31, 2021 is 0%.
Predictive Technology Annual Profit Margins
Predictive Technology Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.000B $0.000B
Predictive Technology Group, Inc. is a therapeutics and life sciences company, in the use of data analytics for disease identification and subsequent therapeutic intervention through unique novel gene-based diagnostics, biotechnology treatments and companion therapeutics. The company through its' wholly-owned subsidiaries Predictive Therapeutics and Predictive Biotech focuses on clinical categories consists of Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. Predictive Biotech efforts to advance regenerative medicine and Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis via appropriate early-stage diagnosis and subsequent treatment. Predictive Technology Group, Inc. is based in Salt Lake City, UT.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.087B 0.00
IRhythm Technologies (IRTC) United States $3.621B 0.00
Axonics (AXNX) United States $3.390B 0.00
10x Genomics (TXG) United States $3.287B 0.00
Enovis (ENOV) United States $3.042B 23.11
Azenta (AZTA) United States $2.930B 238.82
Olink Holding AB (publ) (OLK) Sweden $2.760B 0.00
Hims & Hers Health (HIMS) United States $2.642B 0.00
Privia Health (PRVA) United States $2.231B 98.95
Schrodinger (SDGR) United States $1.794B 0.00
Omnicell (OMCL) United States $1.306B 31.94
Phreesia (PHR) United States $1.305B 0.00
Definitive Healthcare (DH) United States $0.856B 0.00
Standard BioTools (LAB) United States $0.743B 0.00
Fulgent Genetics (FLGT) United States $0.617B 0.00
Talkspace (TALK) United States $0.530B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.289B 0.00
P3 Health Partners (PIII) United States $0.162B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
American Well (AMWL) United States $0.157B 0.00
Butterfly Network (BFLY) United States $0.154B 0.00
Augmedix (AUGX) United States $0.138B 0.00
Outset Medical (OM) United States $0.127B 0.00
TruBridge (TBRG) United States $0.119B 5.06
111 (YI) China $0.091B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Cue Health (HLTH) United States $0.024B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.014B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00